RNA aptamers selected against the GluR2 glutamate receptor channel

Biochemistry

Volumn 46, Issue 44, 2007, Pages 12648-12655

  Huang, Zhen ^a   Pei, Weimin ^a   Jayaseelan, Sabarinath ^a   Shi, Hua ^a   Niu, Li ^a  

^a STATE UNIVERSITY OF NEW YORK   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMYOTROPHIC LATERAL SCLEROSIS; CEREBRAL ISCHEMEIA; RNA APTAMERS;

CELLS; DISEASES; LIGANDS; RNA;

BIOCHEMISTRY;

6 NITRO 7 SULFAMOYLBENZO[F]QUINOXALINE 2,3 DIONE; AMPA RECEPTOR; AN 1210; AN 1229; AN 1421; AN 1444; AN 58; APTAMER; GLUTAMATE RECEPTOR 2; UNCLASSIFIED DRUG;

AMYOTROPHIC LATERAL SCLEROSIS; ARTICLE; BINDING AFFINITY; BRAIN ISCHEMIA; COMBINATORIAL CHEMISTRY; DRUG RECEPTOR BINDING; DRUG SYNTHESIS; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECEPTOR UPREGULATION;

ANIMALS; ANIMALS, NEWBORN; APTAMERS, NUCLEOTIDE; BASE SEQUENCE; CELLS, CULTURED; HUMANS; MOLECULAR SEQUENCE DATA; NUCLEIC ACID CONFORMATION; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, AMPA; RECOMBINANT PROTEINS; SELEX APTAMER TECHNIQUE; SUBSTRATE SPECIFICITY; TRANSFECTION;

EID: 35848951405     PISSN: 00062960     EISSN: None     Source Type: Journal    
DOI: 10.1021/bi701036p     Document Type: Article

References (55)

1. Dingledine, R., Borges, K., Bowie, D., and Traynelis, S. F. (1999) The glutamate receptor ion channels, Pharmacol. Rev. 51, 7-61.
2. Solyom, S., and Tarnawa, I. (2002) Non-competitive AMPA antagonists of 2,3-benzodiazepine type, Curr. Pharm. Des. 8, 913-939.
3. Li, G., Pei, W., and Niu, L. (2003) Channel-opening kinetics of GluR2Q(flip) AMPA receptor: a laser-pulse photolysis study, Biochemistry 42, 12358-12366.
4. Li, G., Sheng, Z., Huang, Z., and Niu, L. (2005) Kinetic mechanism of channel opening of the GluRDflip AMPA receptor, Biochemistry 44, 5835-5841.
5. Li, G., and Niu, L. (2004) How fast does the GluR1Qflip channel open? J. Biol. Chem. 279, 3990-3997.
6. Pei, W., Huang, Z., and Niu, L. (2007) GluR3 flip and flop: differences in channel opening kinetics, Biochemistry 46, 2027-2036.
7. Nowak, L., Bregestovski, P., Ascher, P., Herbet, A., and Prochiantz, A. (1984) Magnesium gates glutamate-activated channels in mouse central neurones, Nature 307, 462-465.
8. Rosenmund, C., Stern-Bach, Y., and Stevens, C. F. (1998) The tetrameric structure of a glutamate receptor channel, Science 280, 1596-1599.
9. Keinanen, K., Wisden, W., Sommer, B., Werner, P., Herb, A., Verdoorn, T. A., Sakmann, B., and Seeburg, P. H. (1990) A family of AMPA-selective glutamate receptors, Science 249, 556-560.
10. Hollmann, M., Hartley, M., and Heinemann, S. (1991) Ca2+ permeability of KA-AMPA-gated glutamate receptor channels depends on subunit composition, Science 252, 851-853.
11. Hume, R. I., Dingledine, R., and Heinemann, S. F. (1991) Identification of a site in glutamate receptor subunits that controls calcium permeability, Science 253, 1028-1031.
12. Burnashev, N., Monyer, H., Seeburg, P. H., and Sakmann, B. (1992) Divalent ion permeability of AMPA receptor channels is dominated by the edited form of a single subunit, Neuron 8, 189-198.
13. Jonas, P., and Spruston, N. (1994) Mechanisms shaping glutamate-mediated excitatory postsynaptic currents in the CNS, Curr. Opin. Neurobiol. 4, 366-372.
14. Geiger, J. R., Melcher, T., Koh, D. S., Sakmann, B., Seeburg, P. H., Jonas, P., and Monyer, H. (1995) Relative abundance of subunit mRNAs determines gating and Ca2+ permeability of AMPA receptors in principal neurons and interneurons in rat CNS, Neuron 15, 193-204.
15. Heath, P. R., and Shaw, P. J. (2002) Update on the glutamatergic neurotransmitter system and the role of excitotoxicity in amyotrophic lateral sclerosis, Muscle Nerve 26, 438-458.
16. Honore, T., Davies, S. N., Drejer, J., Fletcher, E. J., Jacobsen, P., Lodge, D., and Nielsen, F. E. (1988) Quinoxalinediones: potent competitive non-NMDA glutamate receptor antagonists, Science 241, 701-703.
17. Weiser, T. (2005) AMPA receptor antagonists for the treatment of stroke, Curr. Drug Targets: CNS Neurol. Disord. 4, 153-159.
18. Nielsen, E. O., Vanning, T., Mathiesen, C., Jensen, L. H., Moller, A., Gouliaev, A. H., Watjen, F., and Drejer, J. (1999) SPD 502: a water-soluble and in vivo long-lasting AMPA antagonist with neuroprotective activity, J. Pharmacol. Exp. Ther. 289, 1492-1501.
19. Turski, L., Huth, A., Sheardown, M., McDonald, F., Neuhaus, R., Schneider, H. H., Dirnagl, U., Wiegand, F., Jacobsen, P., and Ottow, E. (1998) ZK200775: a phosphonate quinoxalinedione AMPA antagonist for neuroprotection in stroke and trauma, Proc. Natl. Acad. Sci. U.S.A. 95, 10960-10965.
20. Hara, H., Yamada, N., Kodama, M., Matsumoto, Y., Wake, Y., and Kuroda, S. (2006) Effect of YM872, a selective and highly water-soluble AMPA receptor antagonist, in the rat kindling and rekindling model of epilepsy, Eur. J. Pharmacol. 531, 59-65.
21. Tuerk, C., and Gold, L. (1990) Systematic evolution of ligands by exponential enrichment: RNA ligands to bacteriophage T4 DNA polymerase, Science 249, 505-510.
22. Ellington, A. D., and Szostak, J. W. (1990) In vitro selection of RNA molecules that bind specific ligands, Nature 346, 818-822.
23. Breaker, R. R. (2004) Natural and engineered nucleic acids as tools to explore biology, Nature 432, 838-845.
24. Lee, J. F., Stovall, G. M., and Ellington, A. D. (2006) Aptamer therapeutics advance, Curr. Opin. Chem. Biol. 10, 282-289.
25. Shi, H., Hoffman, B. E., and Lis, J. T. (1999) RNA aptamers as effective protein antagonists in a multicellular organism, Proc. Natl. Acad. Sci. U.S.A. 96, 10033-10038.
26. Ulrich, H. (2006) RNA aptamers: from basic science towards therapy, Handb. Exp. Pharmacol. 173, 305-326.
27. Blank, M., and Blind, M. (2005) Aptamers as tools for target validation, Curr. Opin. Chem. Biol. 9, 336-342.
28. Huang, Z., Li, G., Pei, W., Sosa, L. A., and Niu, L. (2005) Enhancing protein expression in single HEK 293 cells, J. Neurosci. Methods 142, 159-166.
29. Niu, L., Gee, K. R., Schaper, K., and Hess, G. P. (1996) Synthesis and photochemical properties of a kainate precursor and activation of kainate and AMPA receptor channels on a microsecond time scale, Biochemistry 35, 2030-2036.
30. Fan, X., Shi, H., Adelman, K., and Lis, J. T. (2004) Probing TBP interactions in transcription initiation and reinitiation with RNA aptamers that act in distinct modes, Proc. Natl. Acad. Sci. U.S.A. 101, 6934-6939.
31. Armstrong, N., and Gouaux, E. (2000) Mechanisms for activation and antagonism of an AMPA-sensitive glutamate receptor: crystal structures of the GluR2 ligand binding core, Neuron 28, 165-181.
32. Lukavsky, P. J., and Puglisi, J. D. (2004) Large-scale preparation and purification of polyacrylamide-free RNA oligonucleotides, RNA 10, 889-893.
33. Udgaonkar, J. B., and Hess, G. P. (1987) Chemical kinetic measurements of a mammalian acetylcholine receptor by a fast-reaction technique, Proc. Natl. Acad. Sci. U.S.A. 84, 8758-8762.
34. Kwak, S., and Kawahara, Y. (2005) Deficient RNA editing of GluR2 and neuronal death in amyotropic lateral sclerosis, J. Mol. Med. 83, 110-120.
35. Akbarian, S., Smith, M. A., and Jones, E. G. (1995) Editing for an AMPA receptor subunit RNA in prefrontal cortex and striatum in Alzheimer's disease, Huntington's disease and schizophrenia, Brain Res. 699, 297-304.
36. Greger, I. H., Khatri, L., Kong, X., and Ziff, E. B. (2003) AMPA receptor tetramerization is mediated by Q/R editing, Neuron 40, 763-774.
37. Tomiyama, M., Rodriguez-Puertas, R., Cortes, R., Pazos, A., Palacios, J. M., and Mengod, G. (2002) Flip and flop splice variants of AMPA receptor subunits in the spinal cord of amyotrophic lateral sclerosis, Synapse 45, 245-249.
38. Koike, M., Tsukada, S., Tsuzuki, K., Kijima, H., and Ozawa, S. (2000) Regulation of kinetic properties of GluR2 AMPA receptor channels by alternative splicing, J. Neurosci. 20, 2166-2174.
39. Zuker, M. (2003) Mfold web server for nucleic acid folding and hybridization prediction, Nucleic Acids Res. 31, 3406-3415.
40. Chen, C. H., Chernis, G. A., Hoang, V. Q., and Landgraf, R. (2003) Inhibition of heregulin signaling by an aptamer that preferentially binds to the oligomeric form of human epidermal growth factor receptor-3, Proc. Natl. Acad. Sci. U.S.A. 100, 9226-9231.
41. Mayer, M. L., Ghosal, A., Dolman, N. P., and Jane, D. E. (2006) Crystal structures of the kainate receptor GluR5 ligand binding core dimer with novel GluR5-selective antagonists, J. Neurosci. 26, 2852-2861.
42. Lerma, J. (2006) Kainate receptor physiology, Curr. Opin. Pharmacol. 6, 89-97.
43. Patneau, D. K., Vyklicky, L., Jr., and Mayer, M. L. (1993) Hippocampal neurons exhibit cyclothiazide-sensitive rapidly desensitizing responses to kainate, J. Neurosci. 13, 3496-3509.
44. Oivanen, M., Kuusela, S., and Lonnberg, H. (1998) Kinetics and mechanisms for the cleavage and isomerization of the phosphodiester bonds of RNA by Bronsted acids and bases, Chem. Rev. 98, 961-990.
45. Knight, R., and Yarus, M. (2003) Analyzing partially randomized nucleic acid pools: straight dope on doping, Nucleic Acids Res. 31, e30.
46. Hollmann, M., and Heinemann, S. (1994) Cloned glutamate receptors, Annu. Rev. Neurosci. 17, 31-108.
47. Brody, E. N., and Gold, L. (2000) Aptamers as therapeutic and diagnostic agents, J. Biotechnol. 74, 5-13.
48. Gopinath, S. C. (2007) Methods developed for SELEX, Anal. Bioanal. Chem. 387, 171-182.
49. Ulrich, H., Ippolito, J. E., Pagan, O. R., Eterovic, V. A., Hann, R. M., Shi, H., Lis, J. T., Eldefrawi, M. E., and Hess, G. P. (1998) In vitro selection of RNA molecules that displace cocaine from the membrane-bound nicotinic acetylcholine receptor, Proc. Natl. Acad. Sci. U.S.A. 95, 14051-14056.
50. Cui, Y., Rajasethupathy, P., and Hess, G. P. (2004) Selection of stable RNA molecules that can regulate the channel-opening equilibrium of the membrane-bound γ-aminobutyric acid receptor, Biochemistry 43, 16442-16449.
51. Morris, K. N., Jensen, K. B., Julin, C. M., Weil, M., and Gold, L. (1998) High affinity ligands from in vitro selection: complex targets, Proc. Natl. Acad. Sci. U.S.A. 95, 2902-2907.
52. Shangguan, D., Li, Y., Tang, Z., Cao, Z. C., Chen, H. W., Mallikaratchy, P., Sefah, K., Yang, C. J., and Tan, W. (2006) Aptamers evolved from live cells as effective molecular probes for cancer study, Proc. Natl. Acad. Sci. U.S.A. 103, 11838-11843.
53. Pestourie, C., Cerchia, L., Gombert, K., Aissouni, Y., Boulay, J., De Franciscis, V., Libri, D., Tavitian, B., and Duconge, F. (2006) Comparison of different strategies to select aptamers against a transmembrane protein target, Oligonucleotides 16, 323-335.
54. Mori, T., Oguro, A., Ohtsu, T., and Nakamura, Y. (2004) RNA aptamers selected against the receptor activator of NF-kappaB acquire general affinity to proteins of the tumor necrosis factor receptor family, Nucleic Acids Res. 32, 6120-6128.
55. Blanpied, T. A., Clarke, R. J., and Johnson, J. W. (2005) Amantadine inhibits NMDA receptors by accelerating channel closure during channel block, J. Neurosci. 25, 3312-3322.